• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCAR-T

CAR-T

Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health
The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By Sy MukherjeeOctober 19, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
Health
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
Tech
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
By Laura LorenzettiJune 30, 2015
1
  • 1
1
Most Popular
Law
Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird, and dozens more cars to pay back fraud victimsplaceholder alt text
By Catherina GioinoOctober 5, 2026
Law
Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida propertiesplaceholder alt text
By Catherina GioinoOctober 6, 2026
Success
Retired Warren Buffett now spends his evenings glued to YouTube—watching Glenn Close clips, 1950s commercials, and Uzbekistani talent showsplaceholder alt text
By Preston ForeOctober 6, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.